HbA1c Rapid Quantitative Test

Quantitative immunoassay for glycated hemoglobin measurement reflecting long-term glucose control. Essential for diabetes diagnosis and therapeutic monitoring.

RapidFor HbA1c Rapid Test Kit enables quick detection of glycated hemoglobin for diabetes screening and monitoring. The test delivers reliable results in minutes, supporting point-of-care diagnosis and glycemic control assessment in clinical and laboratory settings.

Quo-Test® is a point-of-care HbA1c measurement device that enables rapid glycemic control assessment at the patient location. The system provides reliable diabetes monitoring results, supporting clinical decision-making in primary care and specialist settings without requiring central laboratory processing.

Rapid quantitative measurement of blood hemoglobin levels. Used for anemia screening and monitoring.

HbA1c Test Kit using dry fluorescence immunoassay technology for rapid point-of-care glycemic control monitoring in diabetes management. Delivers quantitative hemoglobin A1c results for long-term blood glucose assessment, compatible with Lansion's portable and handheld analyzer platforms.

Point-of-care diagnostic test for rapid glucose measurement and diabetes monitoring in clinical settings.

Immunofluorescence-based test kit for quantitative measurement of glycated hemoglobin (HbA1c), enabling rapid diabetes screening and monitoring in clinical and point-of-care settings. Delivers precise glycemic control assessment through advanced immunofluorescence technology for both diagnostic and therapeutic applications.

Quantitative test for blood glucose measurement and diabetes assessment. Supports metabolic disorder evaluation.

Point-of-care test kit for HbA1c measurement using fluorescence immunoassay technology. Enables rapid diabetes monitoring and glycemic control assessment in clinical settings. Delivers quantitative results without laboratory infrastructure requirements.

A rapid immunochromatographic test for the detection of hepatitis B surface antigen, facilitating timely diagnosis and screening in healthcare facilities.

A point-of-care assay for measuring glycated hemoglobin to assess long-term glucose control and support diabetes diagnosis. The test is integrated into Boditech Med's AFIAS platform for rapid results in clinical settings.

A diagnostic test kit for measuring glycated hemoglobin levels using fluorescence immunochromatography technology. It is used for diabetes screening and monitoring in point-of-care testing settings.